Joost S Vermaat - Department of Internal Medicine, St. Antonius Hospital

基本信息

浏览量：18

职业迁徙

个人简介

lymphoma, next generation sequencing, precision medicine

研究兴趣

论文共 134 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

PATIENTS WITH NON-HODGKIN'S LYMPHOMA TREATED WITH CAR T CELL THERAPY ARE AT RISK OF IMPAIRED LEFT VENTRICULAR FUNCTION

Elissa Anne Sophie Polomski,Aniko Sijs-Szabo,Johan Wouter Jukema,Joost Vermaat,Maria Louisa Antoni

Journal of the American College of Cardiologyno. 13 (2024): 2677-2677

引用0浏览0引用

IBCL-278 Epcoritamab with Rituximab + Lenalidomide (R2) in Previously Untreated (1L) Follicular Lymphoma (FL) and Epcoritamab Maintenance Therapy in FL: EPCORE NHL-2 Arms 6 and 7

Lorenzo Falchi,Joost S.P. Vermaat,Gerardo Musuraca,Marcel Nijland,Jacob Haaber Christensen,Fritz Offner,Lori A. Leslie,Joshua D. Brody,Daniela Hoehn,Jennifer Marek, Liwei Wang, Jian Mei,David Belada,Pau Abrisqueta

Clinical Lymphoma Myeloma and Leukemia (2024): S496-S497

引用0浏览0引用

Clinical Characteristics and Survival Outcomes of Patients with Primary Central Nervous System Lymphoma Treated with High-Dose Methotrexate-Based Polychemotherapy and Consolidation Therapies

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0WOS引用

Unveiling Transformation Mechanisms of Nodal Marginal Zone Lymphoma Using a Multi-Omics Approach

Johanna A.A. Bult,Yujie Zhong,Fleur A. De Groot,Ruben A.L. De Groen,Nick Veltmaat,Diana Al-Sarayfi,Wouter Plattel,Joost L. Kluiver,Anke Van Den Berg,Stefano Rosati,Arjan Diepstra,Joost S.P. Vermaat,Marcel Nijland

Bloodno. Supplement 1 (2024): 2984-2984

引用0浏览0引用

Atalanta-1: A Phase 1/2 Trial of GLPG5101, a Fresh, Stem-like, Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

Marie José Kersten,Kirsten Saevels, Evelyne Willems,Marte C. Liefaard, Stavros Milatos, Margot J. Pont, Claire Vennin,Eva Santermans, Anna D. D. van Muyden, Jeevan Shetty, Esmée P. Hoefsmit, Omotayo Fasan,Maria T. Kuipers,Sébastien Anguille,Joost S.P. Vermaat

Bloodno. Supplement 1 (2024): 93-93

引用0浏览0引用

Improved Outcome of COVID-19 over Time in Patients Treated with CAR T-cell Therapy: Update of the European COVID-19 Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

Leukemia (2024)

引用0浏览0WOSNATURE引用

Sinonasal DLBCL: Molecular Profiling Identifies Subtypes with Distinctive Prognosis and Targetable Genetic Features

Patrick R. G. Eriksen,Fleur de Groot,Erik Clasen-Linde,Peter de Nully Brown, Ruben de Groen,Linea C. Melchior,Andrea D. Maier,Marthe Minderman,Joost S. P. Vermaat,Christian von Buchwald,Steven T. Pals,Steffen Heegaard

BLOOD ADVANCESno. 8 (2024): 1946-1957

引用1浏览0WOS引用

Population Pharmacokinetic and Toxicity Analysis of High-Dose Methotrexate in Patients with Central Nervous System Lymphoma

Anyue Yin,Fleur A. de Groot,Henk-Jan Guchelaar,Marcel Nijland,Jeanette K. Doorduijn,Daan J. Touw,Thijs Oude Munnink,Brenda C. M. de Winter,Lena E. Friberg,Joost S. P. Vermaat,Dirk Jan A. R. Moes

Clinical Pharmacokineticspp.1-13, (2024)

引用0浏览0WOS引用

R-miniCHOP Versus R-CHOP in Elderly Patients with Diffuse Large B-cell Lymphoma: A Propensity Matched Population-Based Study

D. Al-Sarayfi,M. Brink,M. E. D. Chamuleau, R. Brouwer,R. S. van Rijn, D. Issa,W. Deenik,G. Huls,R. Mous,J. S. P. Vermaat,A. Diepstra,J. M. Zijlstra,T. van Meerten,M. Nijland

AMERICAN JOURNAL OF HEMATOLOGYno. 2 (2024): 216-222

引用1浏览0WOS引用

Population-Based External Validation of the CAR-Hematotox Score to Predict CAR T Cell Related Toxicity and Outcome in R/R LBCL Patients

Janneke W. de Boer,Kylie Keijzer,Suzanne van Dorp,Pim G.N.J. Mutsaers,Anne G.H. Niezink,Jaap A. van Doesum,Yasmina I.M. Serroukh, Louise W. Muntendam, Astrid E. Pulles, Esther J. Kret,Aniko Sijs-Szabo, Jesse Oomen,Astrid M.P. Demandt,Wendy B.C. Stevens,Maria T. Kuipers,Elise R.A. Pennings,Anne M. Spanjaart,Marie José Kersten,Margot Jak,Lisanne V. van Dijk,Marjolein W.M. van der Poel,Joost S.P. Vermaat,Tom van Meerten

Bloodno. Supplement 1 (2024): 1747-1747

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn